diabetes
Conditions
Interventions
Part One: ungroup:None
Part Two: General lifestyle control group:All the groups were not classified, and the general lifestyle intervention was carried out according to the guidelines.
Part Two: Precise classification of individual intervention group:The classification and intervention were carried out in Beijing Hospital and Beijing Tiantan Hospital Affiliated to Capital Medical Un
The second group is the moderate-risk group of obesity and insulin deficiency, and intensive lifestyle intervention is recommended by reference to the 2020 edition of the Chinese Guidelines for the pr
At least reduce the total daily calories in your diet
400-500kcal (1kcal=4.184kJ), overweight or obese people should reduce 500-750kcal
(3) Saturated fatty acid intake accounted for less than 30% of total fatty acid intake
The total amount of salt per person per day should not exceed 5g
? Moderate intensity physical activity should be maintained at least 150min/ week
The third group is the high-risk insulin resistance type group, which recommends lifestyle +500mg tid metformin intervention.
Part Three: ungroup:None
Sponsors
Beijing hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Part Two and Part Three: (1) Diabetes high-risk groups diagnosed by the identification model; (2) Age 18-75 years old; (3) Sign informed consent and take the test voluntarily;
Exclusion criteria
Exclusion criteria: Part Two and Part Three: (1) Incomplete data; (2) critically ill patients; (3) Patients with mental illness who cannot sign informed consent; (4) Refusing to participate in the survey; (5) can not use artificial intelligence equipment or life can not take care of themselves.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycosylated hemoglobin;Fasting blood glucose;Postprandial blood glucose;weight;Blood pressure;Fasting insulin;triglyceride;cholesterol;Low density lipoprotein cholesterol;High density lipoprotein cholesterol;BMI;Fasting c-peptide;Postprandial C-peptide;Postprandial insulin; | — |
Secondary
| Measure | Time frame |
|---|---|
| Waist-hip circumference;urine protein;urine acetone bodies;Urinary nitrite;glutamic-pyruvic transaminase;glutamic oxalacetic transaminase;total bilirubin;alkaline phosphatase;urea nitrogen;creatinine;height;pulse; | — |
Countries
China
Contacts
Public ContactGuo lixin
Beijing hospital
Outcome results
None listed